Cargando…

What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?

OBJECTIVES: To review the pathophysiology of type 2 diabetes (T2DM), the role ofincretins, the potential of incretin-based therapies to address unmet therapeuticneeds in T2DM, and the potential impact this will have on the contribution of managed care pharmacy to diabetes therapy. SUMMARY: Diabetes,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonde, Lawrence, Rosenstock, Julio, Triplitt, Curtis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438057/
https://www.ncbi.nlm.nih.gov/pubmed/16981805
http://dx.doi.org/10.18553/jmcp.2006.12.S7-A.1
_version_ 1785092701105946624
author Bonde, Lawrence
Rosenstock, Julio
Triplitt, Curtis
author_facet Bonde, Lawrence
Rosenstock, Julio
Triplitt, Curtis
author_sort Bonde, Lawrence
collection PubMed
description OBJECTIVES: To review the pathophysiology of type 2 diabetes (T2DM), the role ofincretins, the potential of incretin-based therapies to address unmet therapeuticneeds in T2DM, and the potential impact this will have on the contribution of managed care pharmacy to diabetes therapy. SUMMARY: Diabetes, the fifth leading cause of death by disease in the United States, costs approximately $132 billion per year in direct and indirect medical expenses. According to the Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey, a majority of diabetes patients do not achieve target A1C levels with their current treatment regimens. Advances in understanding the pathophysiologic abnormalities underlying the metabolic dysfunctions associated with T2DM are leading to the development of new treatment approaches and new therapeutic classes of drugs. Novel incretin-based therapies currently available, andin late-stage development, are among those showing the greatest promise for addressing the unmet needs of traditional therapies.
format Online
Article
Text
id pubmed-10438057
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104380572023-08-21 What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes? Bonde, Lawrence Rosenstock, Julio Triplitt, Curtis J Manag Care Pharm Supplement OBJECTIVES: To review the pathophysiology of type 2 diabetes (T2DM), the role ofincretins, the potential of incretin-based therapies to address unmet therapeuticneeds in T2DM, and the potential impact this will have on the contribution of managed care pharmacy to diabetes therapy. SUMMARY: Diabetes, the fifth leading cause of death by disease in the United States, costs approximately $132 billion per year in direct and indirect medical expenses. According to the Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey, a majority of diabetes patients do not achieve target A1C levels with their current treatment regimens. Advances in understanding the pathophysiologic abnormalities underlying the metabolic dysfunctions associated with T2DM are leading to the development of new treatment approaches and new therapeutic classes of drugs. Novel incretin-based therapies currently available, andin late-stage development, are among those showing the greatest promise for addressing the unmet needs of traditional therapies. Academy of Managed Care Pharmacy 2006-09 /pmc/articles/PMC10438057/ /pubmed/16981805 http://dx.doi.org/10.18553/jmcp.2006.12.S7-A.1 Text en Copyright © 2006, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Supplement
Bonde, Lawrence
Rosenstock, Julio
Triplitt, Curtis
What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
title What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
title_full What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
title_fullStr What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
title_full_unstemmed What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
title_short What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
title_sort what are incretins, and how will they influence the management of type 2 diabetes?
topic Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438057/
https://www.ncbi.nlm.nih.gov/pubmed/16981805
http://dx.doi.org/10.18553/jmcp.2006.12.S7-A.1
work_keys_str_mv AT bondelawrence whatareincretinsandhowwilltheyinfluencethemanagementoftype2diabetes
AT rosenstockjulio whatareincretinsandhowwilltheyinfluencethemanagementoftype2diabetes
AT triplittcurtis whatareincretinsandhowwilltheyinfluencethemanagementoftype2diabetes